|
Volumn 357, Issue 12, 2007, Pages 1258-1259
|
To the editor [12]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MITOTANE;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ADJUVANT THERAPY;
ADRENAL CORTEX CARCINOMA;
CANCER PATIENT;
CANCER RECURRENCE;
DISEASE FREE SURVIVAL;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
GASTROINTESTINAL TOXICITY;
HUMAN;
LETTER;
NEUROTOXICITY;
PRIORITY JOURNAL;
TREATMENT DURATION;
ADJUVANT CHEMOTHERAPY;
ADRENAL CORTEX TUMOR;
CANCER STAGING;
FOLLOW UP;
NOTE;
DOSE RESPONSE;
MULTIVARIATE ANALYSIS;
SURVIVAL;
TUMOR RECURRENCE;
ADRENAL CORTEX NEOPLASMS;
ADRENOCORTICAL CARCINOMA;
ANTINEOPLASTIC AGENTS, HORMONAL;
CHEMOTHERAPY, ADJUVANT;
FOLLOW-UP STUDIES;
HUMANS;
MITOTANE;
NEOPLASM STAGING;
DOSE-RESPONSE RELATIONSHIP, DRUG;
MULTIVARIATE ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
SURVIVAL ANALYSIS;
|
EID: 34548820223
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (6)
|
References (0)
|